SUPN

Business Context and Reporting Period

Company: Supernus Pharmaceuticals, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 9, 2015
Reporting Period: Event-based report regarding investor conference announcements.

Key Financial Metrics

This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document serves solely to announce upcoming corporate events.

Material Changes

No material financial changes or operational updates were reported in this filing. The document discloses the scheduling of management presentations.

Guidance, Outlook, and Management Commentary

Upcoming Events: Management announced plans to present an overview and update of the Company at investor conferences in New York City on the following dates:

• November 17, 2015
• December 1, 2015

Exhibits: A press release dated November 9, 2015, is included as Exhibit 99.1.

Investor Verification Checklist

• Verify the specific dates and locations of the investor conferences (November 17 and December 1, 2015, in New York City).
• Review the attached press release (Exhibit 99.1) for detailed management commentary.
• Consult the most recent 10-Q or 10-K filings for actual financial performance metrics, as this 8-K contains no financial data.